In-depth guide

UPDATED FEB 2026

Part of the Transvaginal Mesh investigation

The short answer

Boston Scientific settled more than 3,000 transvaginal mesh cases for over $188 million, with an average payout of approximately $62,667 — among the highest per-case averages in the mesh litigation. The company's Advantage, Obtryx, Uphold, Pinnacle, and Solyx mesh products are the primary subjects of these claims.

People's Justice Research TeamUpdated February 23, 2026Fact-checked

Verified against court and regulatory records · No upfront fees · Your information is never sold

Free Case Review

Check your eligibility — free

Answer 2-3 quick questions to review your potential case.

Free · Confidential · About 2 minutes · A case specialist responds within 1 business day

Your answers are never sold or shared without your consent.

Boston Scientific manufactured several transvaginal mesh products that were consolidated in MDL 2326 before Judge Goodwin in West Virginia. Its Advantage (SUI sling) and Uphold and Pinnacle (POP repair systems) devices caused erosion, chronic pain, and organ complications in thousands of women. A bellwether trial in 2015 resulted in an $18 million verdict, accelerating settlement negotiations.

Boston Scientific's $188M+ global settlement averaged approximately $62,667 per resolved case — higher than Ethicon's average — reflecting the severity of documented complications in the Boston Scientific plaintiff pool. If you had a Boston Scientific mesh device implanted, including Advantage, Advantage Fit, Obtryx, Uphold, Pinnacle, or Solyx, and experienced complications, individual claims outside the global settlement may still be available.

The full investigation

Part of the Transvaginal Mesh Investigation